Chairman’s
Message

It is my distinct honor and great pleasure to welcome you to the 8th International Lymphoma Conference, taking place from April 2–4, 2026, at the Hilton Hotel in Jeddah, Kingdom of Saudi Arabia. This landmark gathering reflects our continued dedication to advancing excellence in lymphoma research, diagnosis, and patient care.

Over the years, this conference has grown into one of the most significant oncology platforms in the region, bringing together more than 700 to 1,000 clinicians, researchers, and healthcare professionals from across Saudi Arabia and the Middle East. This year, we are privileged to host an outstanding panel of distinguished experts from leading institutions in the United States and Europe, who will present cutting-edge developments and emerging innovations in lymphoma management.

Beyond the scientific program, this conference serves as a vital forum for collaboration, dialogue, and professional networking. It provides a unique opportunity to exchange ideas, share best practices, and strengthen partnerships that will ultimately enhance the quality of care we provide for our patients.

As the Conference Chairman, I extend my sincere gratitude to our speakers, sponsors, partners, and participants for their unwavering support and commitment to this important mission. Your engagement is what makes this conference truly impactful.

Welcome to Jeddah. I look forward to a dynamic, inspiring, and rewarding experience as we move forward together in the fight against lymphoma.